Abstract
Data on the use of oral cyclosporin A (CyA) therapy for severe adult atopic dermatitis (AD) have accumulated since 1987, and CyA has a place in the long-term treatment of severe AD provided that appropriate patients are selected and careful monitoring is performed. We have treated with 30 severe AD patients (19 males and II females) refractory to systemic steroids since 1992, for 1-42 months (M) (mean 12.4M, 1~6M: 13, 7~12M: 6, 13~24M: 9, 25M~: 2). Fourteen of these patients have shown an improvement in their symptoms. Five subjects are still continuing the CyA treatment. Seven subjects were readministered with CyA at each relapse (intermittent therapy); four patients significantly improved, but 2 changed their treatment to topical steroid ointment therapy. Three patients did not want to continue this therapy and returned to systemic steroid therapy. An excebation of the eruptions was seen in one subject. The blood pressure increased slightly in one subject. Based on the present study, CyA was found to produce a rapid and highly significant improvement in 23 patients (76.6%). In addition, no serious side effects were observed even in the long-term therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 271-278 |
| Number of pages | 8 |
| Journal | Nishinihon Journal of Dermatology |
| Volume | 61 |
| Issue number | 3 |
| Publication status | Published - Jan 1 1999 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Dermatology
Cite this
Treatment of severe atopic dermatitis patients with cyclosporin A (CyA) : The long-term safety and efficacy. / Kubota, Y.; Imayama, S.; Miyahara, H.; Tanahashi, T.; Uemura, Y.; Furue, Masutaka.
In: Nishinihon Journal of Dermatology, Vol. 61, No. 3, 01.01.1999, p. 271-278.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of severe atopic dermatitis patients with cyclosporin A (CyA)
T2 - The long-term safety and efficacy
AU - Kubota, Y.
AU - Imayama, S.
AU - Miyahara, H.
AU - Tanahashi, T.
AU - Uemura, Y.
AU - Furue, Masutaka
PY - 1999/1/1
Y1 - 1999/1/1
N2 - Data on the use of oral cyclosporin A (CyA) therapy for severe adult atopic dermatitis (AD) have accumulated since 1987, and CyA has a place in the long-term treatment of severe AD provided that appropriate patients are selected and careful monitoring is performed. We have treated with 30 severe AD patients (19 males and II females) refractory to systemic steroids since 1992, for 1-42 months (M) (mean 12.4M, 1~6M: 13, 7~12M: 6, 13~24M: 9, 25M~: 2). Fourteen of these patients have shown an improvement in their symptoms. Five subjects are still continuing the CyA treatment. Seven subjects were readministered with CyA at each relapse (intermittent therapy); four patients significantly improved, but 2 changed their treatment to topical steroid ointment therapy. Three patients did not want to continue this therapy and returned to systemic steroid therapy. An excebation of the eruptions was seen in one subject. The blood pressure increased slightly in one subject. Based on the present study, CyA was found to produce a rapid and highly significant improvement in 23 patients (76.6%). In addition, no serious side effects were observed even in the long-term therapy.
AB - Data on the use of oral cyclosporin A (CyA) therapy for severe adult atopic dermatitis (AD) have accumulated since 1987, and CyA has a place in the long-term treatment of severe AD provided that appropriate patients are selected and careful monitoring is performed. We have treated with 30 severe AD patients (19 males and II females) refractory to systemic steroids since 1992, for 1-42 months (M) (mean 12.4M, 1~6M: 13, 7~12M: 6, 13~24M: 9, 25M~: 2). Fourteen of these patients have shown an improvement in their symptoms. Five subjects are still continuing the CyA treatment. Seven subjects were readministered with CyA at each relapse (intermittent therapy); four patients significantly improved, but 2 changed their treatment to topical steroid ointment therapy. Three patients did not want to continue this therapy and returned to systemic steroid therapy. An excebation of the eruptions was seen in one subject. The blood pressure increased slightly in one subject. Based on the present study, CyA was found to produce a rapid and highly significant improvement in 23 patients (76.6%). In addition, no serious side effects were observed even in the long-term therapy.
UR - http://www.scopus.com/inward/record.url?scp=0032975016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032975016&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0032975016
VL - 61
SP - 271
EP - 278
JO - Nishinihon Journal of Dermatology
JF - Nishinihon Journal of Dermatology
SN - 0386-9784
IS - 3
ER -